可穿戴注射器市场基于(主要地区、市场参与者、规模和份额)- 预测至 2031 年

  • Report Code : TIPMD00002677
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Wearable Injectors Market Size & CAGR (2023-2031)

Buy Now

2023 年可穿戴注射器市场价值为 89.8 亿美元,预计到 2031 年将达到 216.1 亿美元。预计 2023-2031 年市场复合年增长率为 11.6%。与远程医疗的整合可能仍是可穿戴注射器市场的主要趋势。

可穿戴注射器市场分析

慢性病患病率的上升是推动可穿戴注射器市场的一个因素。老龄化人口也利用了可穿戴医疗技术,因为急性和慢性疾病在世界范围内变得越来越普遍。可穿戴医疗设备的出现恰逢 COVID-19 大流行。例如,根据世界卫生组织的数据,全球约有 4.22 亿人患有糖尿病,其中大多数居住在中低收入国家。该疾病每年直接导致 150 万人死亡。

可穿戴注射器市场概况

由于技术的发展、人们对这些设备的健康意识不断提高以及对个性化医疗保健的需求不断增长,可穿戴医疗设备领域前景光明。由于这些设备的技术进步和创新,可穿戴注射设备市场预计将在新兴国家增长。心血管疾病和糖尿病的增加预计将大大加速市场扩​​张。例如,预计在中国,2020 年至 2030 年间,20 至 79 岁糖尿病患者的比例将从 8.2% 上升至 9.7%。

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

可穿戴注射器市场:

Wearable Injectors Market: Strategic Insights

Wearable Injectors Market

  • CAGR (2023 - 2031)
    11.6%
  • Market Size 2023
    US$ 8.98 Billion
  • Market Size 2031
    US$ 21.61 Billion

Key Players

  • Amgen, Inc.
  • Medtronic
  • BD
  • Insulet Corporation
  • Gerresheimer AG (Sensile Medical)
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG
  • Tandem Diabetes Care, Inc.
  • CeQur SA
  • Debiotech S.A

Regional Overview

  • 北美(美国、加拿大、墨西哥)
  • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
  • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
  • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
  • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)

Market Segmentation

类型(体内注射器、体外注射器)
    应用(糖尿病、肿瘤学、心血管疾病、自身免疫性疾病、其他应用)
      最终用户(医院和诊所、家庭护理机构、其他最终用户)

        可穿戴注射器市场

        • 复合年增长率(2023 - 2031)
          11.6%
        • 2023 年市场规模
          89.8 亿美元
        • 2031年市场规模
          216.1亿美元

        市场动态

        增长动力
        • 可穿戴注射器需求激增
        未来的趋势
        • 与远程医疗的整合
        机会
        • 新产品发布和批准

        关键人物;主力;重要一员

        • 安进公司
        • 美敦力
        • 屋宇署
        • 胰岛素公司
        • Gerresheimer AG(Sensile Medical)
        • 西部制药服务有限公司
        • 伊普索梅德公司
        • Tandem 糖尿病护理公司
        • 赛奎公司
        • 德比奥泰克公司

        区域概况

        • 北美
        • 欧洲
        • 亚太
        • 南美洲和中美洲
        • 中东和非洲

        市场细分

        类型
        • 体内注射器
        • 离体注射器
        应用
        • 糖尿病
        • 肿瘤学
        • 心血管疾病
        • 自身免疫性疾病
        • 其他应用
        最终用户
        • 医院和诊所
        • 家庭护理设置
        • 其他最终用户
        • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

        可穿戴注射器市场驱动因素和机遇

        可穿戴注射器需求激增,市场前景看好

        公司致力于向消费者提供可穿戴健康技术并确保其有益。医疗生态系统中的可穿戴设备市场正在迅速增长。根据美国国立卫生研究院的信息,大约 30% 的美国成年人使用可穿戴医疗技术,几乎一半的人每天都在使用以应对复杂的医疗状况。据报道,几家企业正在竞相成为第一个销售可穿戴血压监测仪的公司,这种监测仪有可能取代传统的医院检测。可穿戴注射器行业有望无缝融入日常生活,在医疗保健革命中不可或缺。这些设备已经发展并获得了关注。由于嵌入式系统、传感技术、纳米技术和小型化的进步,智能医疗系统正在成为可能。注射器使用方便、舒适,具有灵活剂量、防水和冷藏药物自动加热等特点。由于这些优势,对注射器的需求日益增长。

        新产品发布和审批——可穿戴注射器市场的机遇

        由于全球大量人口对可穿戴注射器的需求不断增加,医疗保健行业正在持续快速发展,这增加了全球新产品的开发、产品发布和批准。此外,主要的市场参与者参与研发活动,以确保高效产品的创新和开发。近年来,市场发生了各种发展,例如产品发布和批准,可能会创造充足的机会。例如,2024 年 2 月,领先的制药技术公司 LTS LOHMANN Therapie-Systeme AG 宣布其客户之一 Coherus BioSciences, Inc. 推出了 UDENYCA 随身注射器 (OBI),它利用了 LTS Sorrel 可穿戴药物输送平台。) 生物仿制药培非格司亭,称为 UDENYCA (pegfilgrastim-cbqv),在化疗后的第二天给药,以降低发热性中性粒细胞减少症所指示的感染风险。美国食品药品监督管理局(FDA)于2024年12月批准了UDENYCA OBI。

        可穿戴注射器市场报告细分分析

        可穿戴注射器市场分析的关键部分包括类型、应用程序和最终用户。

        • 根据类型,可穿戴注射器市场分为体内注射器和体外注射器。体内注射器部分在 2023 年占据了较大的市场份额。
        • 根据应用,市场细分为糖尿病、肿瘤学、心血管疾病、自身免疫性疾病和其他应用。2023年,肿瘤学领域占据了最大的市场份额。
        • 根据最终用户,可穿戴注射器市场分为医院和诊所、家庭护理环境和其他最终用户。

        可穿戴注射器市场份额按地区分析

        可穿戴注射器市场报告的地理范围分为五个地区:北美、亚太、欧洲、中东和非洲、南美/南美和中美。

        北美主导了可穿戴注射器市场。在北美,美国是 2023 年最大的可穿戴注射器市场。糖尿病、癌症、肿瘤、心血管疾病等慢性病患病率的增加是北美市场不断增长的特征。除了新产品的创造和该领域重要市场参与者的存在。此外,美国糖尿病发病率的上升预计将支持该国可穿戴注射器市场的扩张。根据美国疾病控制和预防中心 (CDC) 2021 年全国糖尿病统计报告,约有 3730 万美国人患有糖尿病,其中 145 万为 1 型糖尿病患者。在北美,由于癌症发病率上升,可穿戴注射器的需求预计将增加。例如,2022 年,美国癌症协会报告称,发现了约 190 万例新癌症病例。美国最常见的癌症包括黑色素瘤、前列腺癌和乳腺癌。此外,医疗技术的发展将为北美的可穿戴注射器市场创造重大机遇。

        可穿戴注射器市场报告范围

        报告属性细节
        2023 年的市场规模89.8亿美元
        2031 年市场规模216.1亿美元
        全球复合年增长率(2023 - 2031)11.6%
        历史数据2021-2022
        预测期2024-2031
        涵盖的领域按类型
        • 体内注射器
        • 离体注射器
        按应用
        • 糖尿病
        • 肿瘤学
        • 心血管疾病
        • 自身免疫性疾病
        • 其他应用
        按最终用户
        • 医院和诊所
        • 家庭护理设置
        • 其他最终用户
        覆盖地区和国家北美
        • 我们
        • 加拿大
        • 墨西哥
        欧洲
        • 英国
        • 德国
        • 法国
        • 俄罗斯
        • 意大利
        • 欧洲其他地区
        亚太
        • 中国
        • 印度
        • 日本
        • 澳大利亚
        • 亚太其他地区
        南美洲和中美洲
        • 巴西
        • 阿根廷
        • 南美洲和中美洲其他地区
        中东和非洲
        • 南非
        • 沙特阿拉伯
        • 阿联酋
        • 中东和非洲其他地区
        市场领导者和主要公司简介
        • 安进公司
        • 美敦力
        • 屋宇署
        • 胰岛素公司
        • Gerresheimer AG(Sensile Medical)
        • 西部制药服务有限公司
        • 伊普索梅德公司
        • Tandem 糖尿病护理公司
        • 赛奎公司
        • 德比奥泰克公司
        • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

        可穿戴注射器市场新闻和最新发展

        可穿戴注射器市场通过收集一手和二手研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下是可穿戴注射器市场的发展和策略列表:

        • Ypsomed 与瑞士全球合同开发和制造组织 ten23 health 建立合作伙伴关系。此次合作的目的是推动 YpsoDose 可穿戴注射器的商业化,用于皮下自我注射大剂量药物。ten23 的药物开发、灌装和设备组装专业知识将为产品供应做出重大贡献。(来源:Ypsomed 公司名称,新闻稿,2024 年)
        • Eitan Medical 是先进输液治疗和药物输送解决方案领域的全球领导者,拥有可靠的创新技术,将患者置于护理的中心。该公司欣然宣布,其可穿戴注射器业务已成功出售并转让给 LTS,后者是一家领先的制药技术公司,开发和制造创新药物输送系统。此次战略收购标志着两家公司的一个里程碑,并为以患者为中心的药物输送系统领域的进一步发展奠定了基础。(来源:Eitan Medical 公司名称,简报,2023 年)

        可穿戴注射器市场报告覆盖范围和交付成果

        “可穿戴注射器市场规模和预测(2021-2031)”报告对市场进行了详细的分析,涵盖以下领域:

        • 范围内所有主要细分市场的全球、区域和国家层面的市场规模和预测
        • 市场动态,如驱动因素、限制因素和关键机遇
        • 未来主要趋势
        • 详细的 PEST/波特五力分析和 SWOT 分析
        • 全球和区域市场分析涵盖关键市场趋势、主要参与者、法规和最新市场发展
        • 行业格局和竞争分析,涵盖市场集中度、热点图分析、知名参与者和最新发展
        • 详细的公司简介

        Wearable Injectors Market Report Scope

        Report Attribute Details
        Market size in US$ 8.98 Billion
        Market Size by US$ 21.61 Billion
        Global CAGR 11.6%
        Historical Data 2021-2022
        Forecast period 2024-2031
        Segments Covered By 类型(体内注射器、体外注射器)
        By 应用(糖尿病、肿瘤学、心血管疾病、自身免疫性疾病、其他应用)
        By 最终用户(医院和诊所、家庭护理机构、其他最终用户)
        Regions and Countries Covered 北美(美国、加拿大、墨西哥)
        • 北美(美国、加拿大、墨西哥)
        欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
        • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
        亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
        • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
        南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
        • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
        中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
        • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
        Market leaders and key company profiles
      • Amgen, Inc.
      • Medtronic
      • BD
      • Insulet Corporation
      • Gerresheimer AG (Sensile Medical)
      • West Pharmaceutical Services, Inc.
      • Ypsomed AG
      • Tandem Diabetes Care, Inc.
      • CeQur SA
      • Debiotech S.A
      • Report Coverage
        Report Coverage

        Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

        Segment Covered
        Segment Covered

        This text is related
        to segments covered.

        Regional Scope
        Regional Scope

        North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

        Country Scope
        Country Scope

        This text is related
        to country scope.

        The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

        1. Data Collection and Secondary Research:

        As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

        Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

        1. Primary Research:

        The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

        For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

        A typical research interview fulfils the following functions:

        • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
        • Validates and strengthens in-house secondary research findings
        • Develops the analysis team’s expertise and market understanding

        Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

        • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
        • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

        Below is the breakup of our primary respondents by company, designation, and region:

        Research Methodology

        Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

        1. Data Analysis:

        Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

        • Macro-Economic Factor Analysis:

        We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

        • Country Level Data:

        Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

        • Company Profile:

        The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

        • Developing Base Number:

        Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

        1. Data Triangulation and Final Review:

        The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

        We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

        We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

        Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

        Related Reports